よむ、つかう、まなぶ。
10参考資料１－２ 成人用肺炎球菌ワクチンファクトシート［4.9MB］ (34 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_70339.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会（第64回 2／12）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
3. 引用文献
1.
杉本恒明, 矢崎義雄, 小俣政男. 内科學. 9 ed: 朝倉書店; 2007: 299-300.
2.
貫和敏博, 高久史麿. 新臨床内科学. 9 ed: 医学書院; 2009: 1306-7.
3.
Otsuka T, Chang B, Shirai T, et al. Individual risk factors associated with nasopharyngeal
colonization with Streptococcus pneumoniae and Haemophilus influenzae: a Japanese birth cohort study. The
Pediatric infectious disease journal 2013; 32(7): 709-14.
4.
Thadchanamoorthy V, Dayasiri K. Review on Pneumococcal Infection in Children. Cureus 2021;
13(5): e14913.
5.
Loughran AJ, Orihuela CJ, Tuomanen EI. Streptococcus pneumoniae: Invasion and Inflammation.
Microbiol Spectr 2019; 7(2).
6.
Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to
pneumococcal disease. Lancet Infect Dis 2004; 4(3): 144-54.
7.
Harrison TR, Longo DL, Fauci AS, et al. ハリソン内科学. 4 ed; 2013: 1004-12.
8.
一般社団法人
9.
Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of
日本呼吸器学会. 成人肺炎診療ガイドライン. 2024.
Infectious Diseases. 9 ed: Elsevier; 2020: 2473-91.
10.
Ganaie F, Saad JS, McGee L, et al. A New Pneumococcal Capsule Type, 10D, is the 100th Serotype
and Has a Large cps Fragment from an Oral Streptococcus. mBio 2020; 11(3).
11.
Johnson HL, Deloria-Knoll M, Levine OS, et al. Systematic evaluation of serotypes causing invasive
pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 2010;
7(10).
12.
Grabenstein JD, Musey LK. Differences in serious clinical outcomes of infection caused by specific
pneumococcal serotypes among adults. Vaccine 2014; 32(21): 2399-405.
13.
Aydin MA, Janapatla RP, Chen CL, Li HC, Su LH, Chiu CH. Microbiological and clinical
characteristics of Streptococcus pneumoniae serotype 3 infection and risk factors for severe outcome: A
multicenter observational study. J Microbiol Immunol Infect 2023; 56(3): 598-604.
14.
Demirdal T, Sen P, Emir B. Predictors of mortality in invasive pneumococcal disease: a meta-
analysis. Expert Rev Anti Infect Ther 2021; 19(7): 927-44.
15.
Ikuse T, Habuka R, Wakamatsu Y, et al. Local outbreak of Streptococcus pneumoniae serotype 12F
caused high morbidity and mortality among children and adults. Epidemiol Infect 2018; 146(14): 1793-6.
16.
Nakano S, Fujisawa T, Ito Y, et al. Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive
Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015-2017.
Emerg Infect Dis 2020; 26(11): 2660-8.
17.
Orenstein WA, Offit PA, Edwards KM, Plotkin SA. Plotkin's Vaccines. 8 ed: Elsevier; 2024: 869-89.
18.
Arguedas A, Trzciński K, O'Brien KL, et al. Upper respiratory tract colonization with Streptococcus
pneumoniae in adults. Expert Rev Vaccines 2020; 19(4): 353-66.
19.
Regev-Yochay G, Raz M, Dagan R, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by
adults and children in community and family settings. Clin Infect Dis 2004; 38(5): 632-9.
34
1.
杉本恒明, 矢崎義雄, 小俣政男. 内科學. 9 ed: 朝倉書店; 2007: 299-300.
2.
貫和敏博, 高久史麿. 新臨床内科学. 9 ed: 医学書院; 2009: 1306-7.
3.
Otsuka T, Chang B, Shirai T, et al. Individual risk factors associated with nasopharyngeal
colonization with Streptococcus pneumoniae and Haemophilus influenzae: a Japanese birth cohort study. The
Pediatric infectious disease journal 2013; 32(7): 709-14.
4.
Thadchanamoorthy V, Dayasiri K. Review on Pneumococcal Infection in Children. Cureus 2021;
13(5): e14913.
5.
Loughran AJ, Orihuela CJ, Tuomanen EI. Streptococcus pneumoniae: Invasion and Inflammation.
Microbiol Spectr 2019; 7(2).
6.
Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to
pneumococcal disease. Lancet Infect Dis 2004; 4(3): 144-54.
7.
Harrison TR, Longo DL, Fauci AS, et al. ハリソン内科学. 4 ed; 2013: 1004-12.
8.
一般社団法人
9.
Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of
日本呼吸器学会. 成人肺炎診療ガイドライン. 2024.
Infectious Diseases. 9 ed: Elsevier; 2020: 2473-91.
10.
Ganaie F, Saad JS, McGee L, et al. A New Pneumococcal Capsule Type, 10D, is the 100th Serotype
and Has a Large cps Fragment from an Oral Streptococcus. mBio 2020; 11(3).
11.
Johnson HL, Deloria-Knoll M, Levine OS, et al. Systematic evaluation of serotypes causing invasive
pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 2010;
7(10).
12.
Grabenstein JD, Musey LK. Differences in serious clinical outcomes of infection caused by specific
pneumococcal serotypes among adults. Vaccine 2014; 32(21): 2399-405.
13.
Aydin MA, Janapatla RP, Chen CL, Li HC, Su LH, Chiu CH. Microbiological and clinical
characteristics of Streptococcus pneumoniae serotype 3 infection and risk factors for severe outcome: A
multicenter observational study. J Microbiol Immunol Infect 2023; 56(3): 598-604.
14.
Demirdal T, Sen P, Emir B. Predictors of mortality in invasive pneumococcal disease: a meta-
analysis. Expert Rev Anti Infect Ther 2021; 19(7): 927-44.
15.
Ikuse T, Habuka R, Wakamatsu Y, et al. Local outbreak of Streptococcus pneumoniae serotype 12F
caused high morbidity and mortality among children and adults. Epidemiol Infect 2018; 146(14): 1793-6.
16.
Nakano S, Fujisawa T, Ito Y, et al. Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive
Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015-2017.
Emerg Infect Dis 2020; 26(11): 2660-8.
17.
Orenstein WA, Offit PA, Edwards KM, Plotkin SA. Plotkin's Vaccines. 8 ed: Elsevier; 2024: 869-89.
18.
Arguedas A, Trzciński K, O'Brien KL, et al. Upper respiratory tract colonization with Streptococcus
pneumoniae in adults. Expert Rev Vaccines 2020; 19(4): 353-66.
19.
Regev-Yochay G, Raz M, Dagan R, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by
adults and children in community and family settings. Clin Infect Dis 2004; 38(5): 632-9.
34